Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Lustman

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Journal of Affective Disorders|October 6, 2020
Depression and Buprenorphine Treatment in Patients with Non-cancer Pain and Prescription Opioid Dependence without Comorbid Substance Use DisordersJeffrey F Scherrer, Joanne Salas, Richard Grucza, et al.
Annals of Neurology|July 31, 2019
A Trial of Sertraline or Cognitive Behavior Therapy for Depression in EpilepsyFrank G Gilliam, Kevin J Black, Jewell Carter, et al.
The International Journal on Drug Policy|June 7, 2021
Opioid dosing among patients with 3 or more years of continuous prescription opioid use before and after the CDC opioid prescribing guidelineJoanne Salas, Xue Li, Hong Xian, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|April 27, 2018
Association between posttraumatic stress disorder and lack of exercise, poor diet, obesity, and co-occuring smoking: A systematic review and meta-analysisCarissa van den Berk-Clark, Scott Secrest, Jesse Walls, et al.
International Journal of Psychiatry in Medicine|December 20, 2002
Anxiety and poor glycemic control: a meta-analytic review of the literatureRyan J Anderson, Allison B Grigsby, Kenneth E Freedland, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
New depression diagnosis following prescription of codeine, hydrocodone or oxycodoneJeffrey F Scherrer, Joanne Salas, Kathleen K Bucholz, et al.
Journal of General Internal Medicine|October 30, 2013
Prescription opioid analgesics increase the risk of depressionJeffrey F Scherrer, Dragan M Svrakic, Kenneth E Freedland, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|March 24, 2011
A test for common genetic and environmental vulnerability to depression and diabetesJeffrey F Scherrer, Hong Xian, Patrick J Lustman, et al.
Missouri Medicine|October 17, 2018
Prescription Opioid Analgesics Increase Risk of Major Depression: New Evidence, Plausible Neurobiological Mechanisms and Management to Achieve Depression ProphylaxisKatherine Semenkovich, Ravikumar Chockalingam, Jeffrey F Scherrer, et al.
Preventive Medicine|August 8, 2016
The influence of prescription opioid use duration and dose on development of treatment resistant depressionJeffrey F Scherrer, Joanne Salas, Mark D Sullivan, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Journal of Affective Disorders|October 6, 2020
Depression and Buprenorphine Treatment in Patients with Non-cancer Pain and Prescription Opioid Dependence without Comorbid Substance Use DisordersJeffrey F Scherrer, Joanne Salas, Richard Grucza, et al.
Annals of Neurology|July 31, 2019
A Trial of Sertraline or Cognitive Behavior Therapy for Depression in EpilepsyFrank G Gilliam, Kevin J Black, Jewell Carter, et al.
The International Journal on Drug Policy|June 7, 2021
Opioid dosing among patients with 3 or more years of continuous prescription opioid use before and after the CDC opioid prescribing guidelineJoanne Salas, Xue Li, Hong Xian, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|April 27, 2018
Association between posttraumatic stress disorder and lack of exercise, poor diet, obesity, and co-occuring smoking: A systematic review and meta-analysisCarissa van den Berk-Clark, Scott Secrest, Jesse Walls, et al.
International Journal of Psychiatry in Medicine|December 20, 2002
Anxiety and poor glycemic control: a meta-analytic review of the literatureRyan J Anderson, Allison B Grigsby, Kenneth E Freedland, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
New depression diagnosis following prescription of codeine, hydrocodone or oxycodoneJeffrey F Scherrer, Joanne Salas, Kathleen K Bucholz, et al.
Journal of General Internal Medicine|October 30, 2013
Prescription opioid analgesics increase the risk of depressionJeffrey F Scherrer, Dragan M Svrakic, Kenneth E Freedland, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|March 24, 2011
A test for common genetic and environmental vulnerability to depression and diabetesJeffrey F Scherrer, Hong Xian, Patrick J Lustman, et al.
Missouri Medicine|October 17, 2018
Prescription Opioid Analgesics Increase Risk of Major Depression: New Evidence, Plausible Neurobiological Mechanisms and Management to Achieve Depression ProphylaxisKatherine Semenkovich, Ravikumar Chockalingam, Jeffrey F Scherrer, et al.
Preventive Medicine|August 8, 2016
The influence of prescription opioid use duration and dose on development of treatment resistant depressionJeffrey F Scherrer, Joanne Salas, Mark D Sullivan, et al.
Pageof 9